Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.169
Filtrar
Más filtros

Intervalo de año de publicación
1.
PLoS Biol ; 20(1): e3001523, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-35061668

RESUMEN

Bacteria have membrane-spanning efflux pumps to secrete toxic compounds ranging from heavy metal ions to organic chemicals, including antibiotic drugs. The overall architecture of these efflux pumps is highly conserved: with an inner membrane energy-transducing subunit coupled via an adaptor protein to an outer membrane conduit subunit that enables toxic compounds to be expelled into the environment. Here, we map the distribution of efflux pumps across bacterial lineages to show these proteins are more widespread than previously recognised. Complex phylogenetics support the concept that gene cassettes encoding the subunits for these pumps are commonly acquired by horizontal gene transfer. Using TolC as a model protein, we demonstrate that assembly of conduit subunits into the outer membrane uses the chaperone TAM to physically organise the membrane-embedded staves of the conduit subunit of the efflux pump. The characteristics of this assembly pathway have impact for the acquisition of efflux pumps across bacterial species and for the development of new antimicrobial compounds that inhibit efflux pump function.


Asunto(s)
Proteínas de la Membrana Bacteriana Externa/metabolismo , Escherichia coli/fisiología , Chaperonas Moleculares , Membrana Externa Bacteriana/fisiología , Transporte Biológico , Farmacorresistencia Bacteriana/fisiología , Proteínas de Escherichia coli , Proteínas de Transporte de Membrana , Filogenia
2.
Proc Natl Acad Sci U S A ; 119(8)2022 02 22.
Artículo en Inglés | MEDLINE | ID: mdl-35193963

RESUMEN

Gram-negative bacteria pose a serious public health concern due to resistance to many antibiotics, caused by the low permeability of their outer membrane (OM). Effective antibiotics use porins in the OM to reach the interior of the cell; thus, understanding permeation properties of OM porins is instrumental to rationally develop broad-spectrum antibiotics. A functionally important feature of OM porins is undergoing open-closed transitions that modulate their transport properties. To characterize the molecular basis of these transitions, we performed an extensive set of molecular dynamics (MD) simulations of Escherichia coli OM porin OmpF. Markov-state analysis revealed that large-scale motion of an internal loop, L3, underlies the transition between energetically stable open and closed states. The conformation of L3 is controlled by H bonds between highly conserved acidic residues on the loop and basic residues on the OmpF ß-barrel. Mutation of key residues important for the loop's conformation shifts the equilibrium between open and closed states and regulates translocation of permeants (ions and antibiotics), as observed in the simulations and validated by our whole-cell accumulation assay. Notably, one mutant system G119D, which we find to favor the closed state, has been reported in clinically resistant bacterial strains. Overall, our accumulated ∼200 µs of simulation data (the wild type and mutants) along with experimental assays suggest the involvement of internal loop dynamics in permeability of OM porins and antibiotic resistance in Gram-negative bacteria.


Asunto(s)
Antibacterianos/metabolismo , Farmacorresistencia Bacteriana/fisiología , Porinas/metabolismo , Antibacterianos/farmacología , Proteínas de la Membrana Bacteriana Externa/metabolismo , Proteínas Bacterianas/metabolismo , Farmacorresistencia Bacteriana/genética , Escherichia coli/genética , Bacterias Gramnegativas/metabolismo , Pruebas de Sensibilidad Microbiana , Modelos Teóricos , Simulación de Dinámica Molecular , Permeabilidad , Porinas/fisiología , Porinas/ultraestructura
3.
PLoS Biol ; 18(4): e3000465, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32310938

RESUMEN

Countering the rise of antibiotic-resistant pathogens requires improved understanding of how resistance emerges and spreads in individual species, which are often embedded in complex microbial communities such as the human gut microbiome. Interactions with other microorganisms in such communities might suppress growth and resistance evolution of individual species (e.g., via resource competition) but could also potentially accelerate resistance evolution via horizontal transfer of resistance genes. It remains unclear how these different effects balance out, partly because it is difficult to observe them directly. Here, we used a gut microcosm approach to quantify the effect of three human gut microbiome communities on growth and resistance evolution of a focal strain of Escherichia coli. We found the resident microbial communities not only suppressed growth and colonisation by focal E. coli but also prevented it from evolving antibiotic resistance upon exposure to a beta-lactam antibiotic. With samples from all three human donors, our focal E. coli strain only evolved antibiotic resistance in the absence of the resident microbial community, even though we found resistance genes, including a highly effective resistance plasmid, in resident microbial communities. We identified physical constraints on plasmid transfer that can explain why our focal strain failed to acquire some of these beneficial resistance genes, and we found some chromosomal resistance mutations were only beneficial in the absence of the resident microbiota. This suggests, depending on in situ gene transfer dynamics, interactions with resident microbiota can inhibit antibiotic-resistance evolution of individual species.


Asunto(s)
Farmacorresistencia Bacteriana/fisiología , Escherichia coli K12/efectos de los fármacos , Microbioma Gastrointestinal/fisiología , Ampicilina/farmacología , Antibacterianos/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Escherichia coli K12/genética , Escherichia coli K12/crecimiento & desarrollo , Escherichia coli K12/fisiología , Proteínas de Escherichia coli/genética , Heces/microbiología , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Mutación , Plásmidos
4.
Mol Cell ; 59(1): 9-21, 2015 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-26051177

RESUMEN

Within bacterial populations, a small fraction of persister cells is transiently capable of surviving exposure to lethal doses of antibiotics. As a bet-hedging strategy, persistence levels are determined both by stochastic induction and by environmental stimuli called responsive diversification. Little is known about the mechanisms that link the low frequency of persisters to environmental signals. Our results support a central role for the conserved GTPase Obg in determining persistence in Escherichia coli in response to nutrient starvation. Obg-mediated persistence requires the stringent response alarmone (p)ppGpp and proceeds through transcriptional control of the hokB-sokB type I toxin-antitoxin module. In individual cells, increased Obg levels induce HokB expression, which in turn results in a collapse of the membrane potential, leading to dormancy. Obg also controls persistence in Pseudomonas aeruginosa and thus constitutes a conserved regulator of antibiotic tolerance. Combined, our findings signify an important step toward unraveling shared genetic mechanisms underlying persistence.


Asunto(s)
Proteínas Bacterianas/genética , Toxinas Bacterianas/biosíntesis , Farmacorresistencia Bacteriana/fisiología , Proteínas de Escherichia coli/biosíntesis , Escherichia coli/genética , Proteínas de Unión al GTP/genética , Pseudomonas aeruginosa/genética , Antibacterianos/farmacología , Toxinas Bacterianas/genética , Membrana Celular/fisiología , Proteínas de Escherichia coli/genética , Potenciales de la Membrana/genética , Pruebas de Sensibilidad Microbiana , Estructura Terciaria de Proteína/genética
5.
Mol Cell ; 59(1): 1-3, 2015 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-26140365

RESUMEN

In this issue of Molecular Cell, Verstraeten et al. (2015) demonstrate that the conserved GTPase Obg and the second messenger ppGpp mediate persistence by activation of a type I toxin-antitoxin module (hokB/sokB) in E. coli.


Asunto(s)
Proteínas Bacterianas/genética , Toxinas Bacterianas/biosíntesis , Farmacorresistencia Bacteriana/fisiología , Proteínas de Escherichia coli/biosíntesis , Escherichia coli/genética , Proteínas de Unión al GTP/genética , Pseudomonas aeruginosa/genética
6.
Proc Natl Acad Sci U S A ; 117(41): 25523-25531, 2020 10 13.
Artículo en Inglés | MEDLINE | ID: mdl-32999060

RESUMEN

Antibiotic resistance in clinically important bacteria can be mediated by target protection mechanisms, whereby a protein binds to the drug target and protects it from the inhibitory effects of the antibiotic. The most prevalent source of clinical resistance to the antibiotic fusidic acid (FA) is expression of the FusB family of proteins that bind to the drug target (Elongation factor G [EF-G]) and promote dissociation of EF-G from FA-stalled ribosome complexes. FusB binding causes changes in both the structure and conformational flexibility of EF-G, but which of these changes drives FA resistance was not understood. We present here detailed characterization of changes in the conformational flexibility of EF-G in response to FusB binding and show that these changes are responsible for conferring FA resistance. Binding of FusB to EF-G causes a significant change in the dynamics of domain III of EF-GC3 that leads to an increase in a minor, more disordered state of EF-G domain III. This is sufficient to overcome the steric block of transmission of conformational changes within EF-G by which FA prevents release of EF-G from the ribosome. This study has identified an antibiotic resistance mechanism mediated by allosteric effects on the dynamics of the drug target.


Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas , Farmacorresistencia Bacteriana/fisiología , Ácido Fusídico/farmacología , Factor G de Elongación Peptídica , Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Modelos Moleculares , Factor G de Elongación Peptídica/química , Factor G de Elongación Peptídica/metabolismo , Conformación Proteica , Dominios Proteicos
7.
Proc Natl Acad Sci U S A ; 117(21): 11207-11216, 2020 05 26.
Artículo en Inglés | MEDLINE | ID: mdl-32424102

RESUMEN

Bacteria frequently encounter selection by both antibiotics and lytic bacteriophages. However, the evolutionary interactions between antibiotics and phages remain unclear, in particular, whether and when phages can drive evolutionary trade-offs with antibiotic resistance. Here, we describe Escherichia coli phage U136B, showing it relies on two host factors involved in different antibiotic resistance mechanisms: 1) the efflux pump protein TolC and 2) the structural barrier molecule lipopolysaccharide (LPS). Since TolC and LPS contribute to antibiotic resistance, phage U136B should select for their loss or modification, thereby driving a trade-off between phage resistance and either of the antibiotic resistance mechanisms. To test this hypothesis, we used fluctuation experiments and experimental evolution to obtain phage-resistant mutants. Using these mutants, we compared the accessibility of specific mutations (revealed in the fluctuation experiments) to their actual success during ecological competition and coevolution (revealed in the evolution experiments). Both tolC and LPS-related mutants arise readily during fluctuation assays, with tolC mutations becoming more common during the evolution experiments. In support of the trade-off hypothesis, phage resistance via tolC mutations occurs with a corresponding reduction in antibiotic resistance in many cases. However, contrary to the hypothesis, some phage resistance mutations pleiotropically confer increased antibiotic resistance. We discuss the molecular mechanisms underlying this surprising pleiotropic result, consideration for applied phage biology, and the importance of ecology in evolution of phage resistance. We envision that phages may be useful for the reversal of antibiotic resistance, but such applications will need to account for unexpected pleiotropy and evolutionary context.


Asunto(s)
Colifagos/fisiología , Farmacorresistencia Bacteriana/fisiología , Escherichia coli/efectos de los fármacos , Escherichia coli/fisiología , Pleiotropía Genética , Antibacterianos/farmacología , Proteínas de la Membrana Bacteriana Externa/genética , Escherichia coli/virología , Proteínas de Escherichia coli/genética , Biblioteca de Genes , Genes Bacterianos , Especificidad del Huésped , Lipopolisacáridos/genética , Lipopolisacáridos/metabolismo , Proteínas de Transporte de Membrana/genética , Mutación
8.
Mol Microbiol ; 116(2): 516-537, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-33892520

RESUMEN

Pseudomonas aeruginosa is an opportunistic pathogen that uses malonate among its many carbon sources. We recently reported that, when grown in blood from trauma patients, P. aeruginosa expression of malonate utilization genes was upregulated. In this study, we explored the role of malonate utilization and its contribution to P. aeruginosa virulence. We grew P. aeruginosa strain PA14 in M9 minimal medium containing malonate (MM9) or glycerol (GM9) as a sole carbon source and assessed the effect of the growth on quorum sensing, virulence factors, and antibiotic resistance. Growth of PA14 in MM9, compared to GM9, reduced the production of elastases, rhamnolipids, and pyoverdine; enhanced the production of pyocyanin and catalase; and increased its sensitivity to norfloxacin. Growth in MM9 decreased extracellular levels of N-acylhomoserine lactone autoinducers, an effect likely associated with increased pH of the culture medium; but had little effect on extracellular levels of PQS. At 18 hr of growth in MM9, PA14 formed biofilm-like structures or aggregates that were associated with biomineralization, which was related to increased pH of the culture medium. These results suggest that malonate significantly impacts P. aeruginosa pathogenesis by influencing the quorum sensing systems, the production of virulence factors, biofilm formation, and antibiotic resistance.


Asunto(s)
Biopelículas/crecimiento & desarrollo , Farmacorresistencia Bacteriana/fisiología , Malonatos/metabolismo , Pseudomonas aeruginosa/patogenicidad , Percepción de Quorum/fisiología , Antibacterianos/farmacología , Biomineralización/fisiología , Catalasa/biosíntesis , Decanoatos , Disacáridos/biosíntesis , Glicerol/metabolismo , Norfloxacino/farmacología , Oligopéptidos/biosíntesis , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/metabolismo , Piocianina/biosíntesis , Serina Endopeptidasas/biosíntesis , Virulencia , Factores de Virulencia/metabolismo
9.
EMBO J ; 37(9)2018 05 02.
Artículo en Inglés | MEDLINE | ID: mdl-29572241

RESUMEN

Bacterial populations can use bet-hedging strategies to cope with rapidly changing environments. One example is non-growing cells in clonal bacterial populations that are able to persist antibiotic treatment. Previous studies suggest that persisters arise in bacterial populations either stochastically through variation in levels of global signalling molecules between individual cells, or in response to various stresses. Here, we show that toxins used in contact-dependent growth inhibition (CDI) create persisters upon direct contact with cells lacking sufficient levels of CdiI immunity protein, which would otherwise bind to and neutralize toxin activity. CDI-mediated persisters form through a feedforward cycle where the toxic activity of the CdiA toxin increases cellular (p)ppGpp levels, which results in Lon-mediated degradation of the immunity protein and more free toxin. Thus, CDI systems mediate a population density-dependent bet-hedging strategy, where the fraction of non-growing cells is increased only when there are many cells of the same genotype. This may be one of the mechanisms of how CDI systems increase the fitness of their hosts.


Asunto(s)
Nucleótidos de Citosina/metabolismo , Farmacorresistencia Bacteriana/fisiología , Proteínas de Escherichia coli/metabolismo , Escherichia coli/crecimiento & desarrollo , Proteínas de la Membrana/metabolismo , Nucleótidos de Citosina/genética , Escherichia coli/genética , Proteínas de Escherichia coli/genética , Genotipo , Proteínas de la Membrana/genética
10.
PLoS Comput Biol ; 17(1): e1008529, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33411759

RESUMEN

Phenomenological relations such as Ohm's or Fourier's law have a venerable history in physics but are still scarce in biology. This situation restrains predictive theory. Here, we build on bacterial "growth laws," which capture physiological feedback between translation and cell growth, to construct a minimal biophysical model for the combined action of ribosome-targeting antibiotics. Our model predicts drug interactions like antagonism or synergy solely from responses to individual drugs. We provide analytical results for limiting cases, which agree well with numerical results. We systematically refine the model by including direct physical interactions of different antibiotics on the ribosome. In a limiting case, our model provides a mechanistic underpinning for recent predictions of higher-order interactions that were derived using entropy maximization. We further refine the model to include the effects of antibiotics that mimic starvation and the presence of resistance genes. We describe the impact of a starvation-mimicking antibiotic on drug interactions analytically and verify it experimentally. Our extended model suggests a change in the type of drug interaction that depends on the strength of resistance, which challenges established rescaling paradigms. We experimentally show that the presence of unregulated resistance genes can lead to altered drug interaction, which agrees with the prediction of the model. While minimal, the model is readily adaptable and opens the door to predicting interactions of second and higher-order in a broad range of biological systems.


Asunto(s)
Antibacterianos/farmacología , Bacterias , Interacciones Farmacológicas/fisiología , Modelos Biológicos , Bacterias/efectos de los fármacos , Bacterias/genética , Fenómenos Biofísicos , Farmacorresistencia Bacteriana/efectos de los fármacos , Farmacorresistencia Bacteriana/genética , Farmacorresistencia Bacteriana/fisiología , Retroalimentación Fisiológica/efectos de los fármacos , Ribosomas/efectos de los fármacos
11.
PLoS Pathog ; 15(7): e1007885, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-31323074

RESUMEN

Colonies of the opportunistic pathogen Proteus mirabilis can distinguish self from non-self: in swarming colonies of two different strains, one strain excludes the other from the expanding colony edge. Predominant models characterize bacterial kin discrimination as immediate antagonism towards non-kin cells, typically through delivery of toxin effector molecules from one cell into its neighbor. Upon effector delivery, receiving cells must either neutralize it by presenting a cognate anti-toxin as would a clonal sibling, or suffer cell death or irreversible growth inhibition as would a non-kin cell. Here we expand this paradigm to explain the non-lethal Ids self-recognition system, which stops access to a social behavior in P. mirabilis by selectively and transiently inducing non-self cells into a growth-arrested lifestyle incompatible with cooperative swarming. This state is characterized by reduced expression of genes associated with protein synthesis, virulence, and motility, and also causes non-self cells to tolerate previously lethal concentrations of antibiotics. We show that temporary activation of the stringent response is necessary for entry into this state, ultimately resulting in the iterative exclusion of non-self cells as a swarm colony migrates outwards. These data clarify the intricate connection between non-lethal recognition and the lifecycle of P. mirabilis swarm colonies.


Asunto(s)
Interacciones Microbianas/fisiología , Proteus mirabilis/fisiología , Proteus mirabilis/patogenicidad , Animales , Farmacorresistencia Bacteriana/genética , Farmacorresistencia Bacteriana/fisiología , Genes Bacterianos , Humanos , Interacciones Microbianas/genética , Modelos Biológicos , Infecciones por Proteus/microbiología , Proteus mirabilis/genética , Transcripción Genética , Sistemas de Secreción Tipo VI/genética , Sistemas de Secreción Tipo VI/fisiología , Infecciones Urinarias/microbiología , Virulencia/genética , Virulencia/fisiología
12.
PLoS Pathog ; 15(3): e1007218, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30875398

RESUMEN

As human population density and antibiotic exposure increase, specialised bacterial subtypes have begun to emerge. Arising among species that are common commensals and infrequent pathogens, antibiotic-resistant 'high-risk clones' have evolved to better survive in the modern human. Here, we show that the major matrix porin (OmpK35) of Klebsiella pneumoniae is not required in the mammalian host for colonisation, pathogenesis, nor for antibiotic resistance, and that it is commonly absent in pathogenic isolates. This is found in association with, but apparently independent of, a highly specific change in the co-regulated partner porin, the osmoporin (OmpK36), which provides enhanced antibiotic resistance without significant loss of fitness in the mammalian host. These features are common in well-described 'high-risk clones' of K. pneumoniae, as well as in unrelated members of this species and similar adaptations are found in other members of the Enterobacteriaceae that share this lifestyle. Available sequence data indicate evolutionary convergence, with implications for the spread of lethal antibiotic-resistant pathogens in humans.


Asunto(s)
Proteínas Bacterianas/fisiología , Farmacorresistencia Bacteriana/genética , Porinas/fisiología , Resistencia betalactámica/genética , Antibacterianos , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Farmacorresistencia Bacteriana/fisiología , Farmacorresistencia Microbiana , Humanos , Infecciones por Klebsiella/genética , Infecciones por Klebsiella/metabolismo , Klebsiella pneumoniae/genética , Klebsiella pneumoniae/patogenicidad , Pruebas de Sensibilidad Microbiana , Porinas/genética , Porinas/metabolismo , Virulencia , Resistencia betalactámica/fisiología , beta-Lactamasas/farmacología
13.
BMC Microbiol ; 21(1): 132, 2021 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-33931013

RESUMEN

BACKGROUND: P. aeruginosa is the primary source of hospital-acquired infections. Unfortunately, antibiotic resistance is growing to precariously high levels, making the infections by this pathogen life-threatening and hard to cure. One possible alternative to antibiotics is to use phages. However, the isolation of phages suitable for phage therapy- be lytic, be efficient, and have a broad host range -against some target bacteria has proven difficult. To identify the best places to look for these phages against P. aeruginosa we screened hospital sewages, soils, and rivers in two cities. RESULTS: We isolated eighteen different phages, determined their host range, infection property, and plaque morphology. We found that the sewage and sewage-contaminated environments are the most reliable sources for the isolation of Pseudomonas phages. In addition, phages isolated from hospital sewage showed the highest efficiency in lysing the bacteria used for host range determination. In contrast, phages from the river had larger plaque size and lysed bacteria with higher levels of antibiotic resistance. CONCLUSIONS: Our findings provided additional support for the importance of sewage as the source of phage isolation.


Asunto(s)
Fagos Pseudomonas/fisiología , Ríos/virología , Aguas del Alcantarillado/virología , Antibacterianos/farmacología , Farmacorresistencia Bacteriana/fisiología , Microbiología Ambiental , Especificidad del Huésped , Humanos , Terapia de Fagos , Infecciones por Pseudomonas/terapia , Fagos Pseudomonas/aislamiento & purificación , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/virología
14.
PLoS Biol ; 16(8): e2005712, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-30130363

RESUMEN

In the malaria parasite P. falciparum, drug resistance generally evolves first in low-transmission settings, such as Southeast Asia and South America. Resistance takes noticeably longer to appear in the high-transmission settings of sub-Saharan Africa, although it may spread rapidly thereafter. Here, we test the hypothesis that competitive suppression of drug-resistant parasites by drug-sensitive parasites may inhibit evolution of resistance in high-transmission settings, where mixed-strain infections are common. We employ a cross-scale model, which simulates within-host (infection) dynamics and between-host (transmission) dynamics of sensitive and resistant parasites for a population of humans and mosquitoes. Using this model, we examine the effects of transmission intensity, selection pressure, fitness costs of resistance, and cross-reactivity between strains on the establishment and spread of resistant parasites. We find that resistant parasites, introduced into the population at a low frequency, are more likely to go extinct in high-transmission settings, where drug-sensitive competitors and high levels of acquired immunity reduce the absolute fitness of the resistant parasites. Under strong selection from antimalarial drug use, however, resistance spreads faster in high-transmission settings than low-transmission ones. These contrasting results highlight the distinction between establishment and spread of resistance and suggest that the former but not the latter may be inhibited in high-transmission settings. Our results suggest that within-host competition is a key factor shaping the evolution of drug resistance in P. falciparum.


Asunto(s)
Adaptación Biológica/fisiología , Interacciones Huésped-Parásitos/fisiología , Plasmodium falciparum/fisiología , África del Sur del Sahara , Animales , Antimaláricos/uso terapéutico , Culicidae , Transmisión de Enfermedad Infecciosa , Resistencia a Medicamentos , Farmacorresistencia Bacteriana/genética , Farmacorresistencia Bacteriana/fisiología , Humanos , Malaria/parasitología , Malaria Falciparum/tratamiento farmacológico , Plasmodium falciparum/efectos de los fármacos , Plasmodium falciparum/genética , Plasmodium falciparum/patogenicidad , América del Sur
15.
Cell Mol Biol Lett ; 26(1): 53, 2021 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-34911439

RESUMEN

Since the discovery of the first MDM2 inhibitors, we have gained deeper insights into the cellular roles of MDM2 and p53. In this review, we focus on MDM2 inhibitors that bind to the p53-binding domain of MDM2 and aim to disrupt the binding of MDM2 to p53. We describe the basic mechanism of action of these MDM2 inhibitors, such as nutlin-3a, summarise the determinants of sensitivity to MDM2 inhibition from p53-dependent and p53-independent points of view and discuss the problems with innate and acquired resistance to MDM2 inhibition. Despite progress in MDM2 inhibitor design and ongoing clinical trials, their broad use in cancer treatment is not fulfilling expectations in heterogenous human cancers. We assess the MDM2 inhibitor types in clinical trials and provide an overview of possible sources of resistance to MDM2 inhibition, underlining the need for patient stratification based on these aspects to gain better clinical responses, including the use of combination therapies for personalised medicine.


Asunto(s)
Antineoplásicos/farmacología , Farmacorresistencia Bacteriana/fisiología , Neoplasias/tratamiento farmacológico , Proteínas Proto-Oncogénicas c-mdm2/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Ensayos Clínicos como Asunto , Farmacorresistencia Bacteriana/efectos de los fármacos , Humanos , Terapia Molecular Dirigida/métodos , Proteínas Proto-Oncogénicas c-mdm2/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-mdm2/genética , Proteína p53 Supresora de Tumor/antagonistas & inhibidores , Proteína p53 Supresora de Tumor/genética
16.
Lett Appl Microbiol ; 73(1): 54-63, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33765334

RESUMEN

Lactic Acid Bacteria (LAB) regulate and maintain the stability of healthy microbial flora, inhibit the adhesion of pathogenic bacteria and promote the colonization of beneficial micro-organisms. The drug resistance and pathogenicity of Salmonella enteritis SE47 isolated from retail eggs were investigated. Meanwhile, Enterococcus faecalis L76 and Lactobacillus salivarius LAB35 were isolated from intestine of chicken. With SE47 as indicator bacteria, the diameters of L76 and LAB35 inhibition zones were 12 mm and 8·5 mm, respectively, by agar inhibition circle method, which indicated that both of them had inhibitory effect on Salmonella, and L76 had better antibacterial effect; two chicken-derived lactic acid bacteria isolates and Salmonella SE47 were incubated with Caco-2. The adhesion index of L76 was 17·5%, which was much higher than that of LAB35 (10·21%) and SE47 (4·89%), this experiment shows that the higher the bacteriostatic effect of potential probiotics, the stronger the adhesion ability; then Caco-2 cells were incubated with different bacteria, and the survival of Caco-2 cells was observed by flow cytometry. Compared with Salmonella SE47, the results showed that lactic acid bacteria isolates could effectively protect Caco-2 cells; finally, after different bacteria incubated Caco-2 cells, according to the cytokine detection kit, the RNA of Caco-2 cells was extracted and transcribed into cDNA, then detected by fluorescence quantitative PCR, the results showed that L76 could protect Caco-2 cells from the invasion of Salmonella SE47, with less cell membrane rupture and lower expression of MIF and TNF genes. Therefore, the lactic acid bacteria isolates can effectively inhibit the adhesion of Salmonella and protect the integrity of intestinal barrier.


Asunto(s)
Antibiosis/fisiología , Huevos/microbiología , Lactobacillales/fisiología , Infecciones por Salmonella/microbiología , Salmonella enterica/fisiología , Animales , Células CACO-2 , Pollos/microbiología , Farmacorresistencia Bacteriana/fisiología , Enterococcus faecalis/aislamiento & purificación , Enterococcus faecalis/fisiología , Humanos , Ligilactobacillus salivarius/aislamiento & purificación , Ligilactobacillus salivarius/fisiología , Probióticos/aislamiento & purificación , Probióticos/farmacología , Salmonella enterica/patogenicidad
17.
Lett Appl Microbiol ; 72(6): 698-705, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33570805

RESUMEN

The aim of this study was to determine the chemical profile of the essential oils (EOs) of three Moroccan lavender species (Lavandula pedunculata, LP; Lavandula angustifolia, LA; and Lavandula maroccana, LM) and to investigate, for the first time, the synergistic effect of the optimal mixture of the EOs with conventional antibiotic ciprofloxacin against three pathogenic foodborne bacteria. Gas chromatography/mass spectrometry analysis showed that eucalyptol (39·05%), camphor (24·21%) and borneol (8·29%) were the dominant compounds of LA-EO. LP-EO was characterized by the abundance of camphor (74·51%) and fenchone (27·06%), whereas carvacrol (42·08%), camphor (17·95%) and fenchone (12·05%) were the main constituents of LM-EO. EOs alone or combined showed a remarkable antimicrobial activity against the tested bacteria with minimum inhibitory concentrations (MICs) ranging from 3·53 to 15·96 mg ml-1 . The optimal mixture, calculated using a mixture design, corresponded to 19% LA, 38% LP and 43% LM. All combination of the EOs and the best EO mixture with ciprofloxacin exhibited a total synergism with fractional inhibitory concentration index values ranging from 0·27 to 0·37. The best EO mixture showed the highest gain of 128-fold, especially against Salmonella spp., more than that found testing the EOs separately. These findings should be taken into consideration for a possible application in the pharmaceutical and food industries.


Asunto(s)
Antibacterianos/farmacología , Ciprofloxacina/farmacología , Lavandula/química , Aceites Volátiles/farmacología , Salmonella/efectos de los fármacos , Canfanos/farmacología , Alcanfor/farmacología , Cimenos/farmacología , Farmacorresistencia Bacteriana/fisiología , Eucaliptol/farmacología , Cromatografía de Gases y Espectrometría de Masas , Pruebas de Sensibilidad Microbiana , Norbornanos/farmacología
18.
Proc Natl Acad Sci U S A ; 115(52): 13359-13364, 2018 12 26.
Artículo en Inglés | MEDLINE | ID: mdl-30545912

RESUMEN

To overcome the action of antibiotics, bacteria have evolved a variety of different strategies, such as drug modification, target mutation, and efflux pumps. Recently, we performed a genome-wide analysis of Listeria monocytogenes gene expression after growth in the presence of antibiotics, identifying genes that are up-regulated upon antibiotic treatment. One of them, lmo0762, is a homolog of hflX, which encodes a heat shock protein that rescues stalled ribosomes by separating their two subunits. To our knowledge, ribosome splitting has never been described as an antibiotic resistance mechanism. We thus investigated the role of lmo0762 in antibiotic resistance. First, we demonstrated that lmo0762 is an antibiotic resistance gene that confers protection against lincomycin and erythromycin, and that we renamed hflXr (hflX resistance). We show that hflXr expression is regulated by a transcription attenuation mechanism relying on the presence of alternative RNA structures and a small ORF encoding a 14 amino acid peptide containing the RLR motif, characteristic of macrolide resistance genes. We also provide evidence that HflXr is involved in ribosome recycling in presence of antibiotics. Interestingly, L. monocytogenes possesses another copy of hflX, lmo1296, that is not involved in antibiotic resistance. Phylogenetic analysis shows several events of hflXr duplication in prokaryotes and widespread presence of hflXr in Firmicutes. Overall, this study reveals the Listeria hflXr as the founding member of a family of antibiotic resistance genes. The resistance conferred by this gene is probably of importance in the environment and within microbial communities.


Asunto(s)
Farmacorresistencia Bacteriana/genética , Proteínas de Escherichia coli/metabolismo , Proteínas de Unión al GTP/metabolismo , Listeria monocytogenes/metabolismo , Antibacterianos/farmacología , Proteínas Bacterianas/metabolismo , Farmacorresistencia Bacteriana/fisiología , Farmacorresistencia Microbiana/efectos de los fármacos , Proteínas de Escherichia coli/genética , Evolución Molecular , Proteínas de Unión al GTP/genética , Listeria monocytogenes/genética , Pruebas de Sensibilidad Microbiana , Filogenia , Proteínas Ribosómicas/metabolismo , Ribosomas/metabolismo
19.
Proc Natl Acad Sci U S A ; 115(38): 9551-9556, 2018 09 18.
Artículo en Inglés | MEDLINE | ID: mdl-30181282

RESUMEN

Microbiome spectra serve as critical clues to elucidate the evolutionary biology pathways, potential pathologies, and even behavioral patterns of the host organisms. Furthermore, exotic sources of microbiota represent an unexplored niche to discover microbial secondary metabolites. However, establishing the bacterial functionality is complicated by an intricate web of interactions inside the microbiome. Here we apply an ultrahigh-throughput (uHT) microfluidic droplet platform for activity profiling of the entire oral microbial community of the Siberian bear to isolate Bacillus strains demonstrating antimicrobial activity against Staphylococcus aureus Genome mining allowed us to identify antibiotic amicoumacin A (Ami) as responsible for inhibiting the growth of S. aureus Proteomics and metabolomics revealed a unique mechanism of Bacillus self-resistance to Ami, based on a subtle equilibrium of its deactivation and activation by kinase AmiN and phosphatase AmiO, respectively. We developed uHT quantitative single-cell analysis to estimate antibiotic efficacy toward different microbiomes and used it to determine the activity spectra of Ami toward human and Siberian bear microbiota. Thus, uHT microfluidic droplet platform activity profiling is a powerful tool for discovering antibiotics and quantifying external influences on a microbiome.


Asunto(s)
Antibacterianos/farmacología , Cumarinas/farmacología , Microbioma Gastrointestinal/efectos de los fármacos , Ensayos Analíticos de Alto Rendimiento/métodos , Metabolómica/métodos , Animales , Antibacterianos/metabolismo , Bacillus pumilus/efectos de los fármacos , Bacillus pumilus/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Cumarinas/metabolismo , ADN Bacteriano/genética , ADN Bacteriano/aislamiento & purificación , Farmacorresistencia Bacteriana/fisiología , Microbioma Gastrointestinal/fisiología , Perfilación de la Expresión Génica , Voluntarios Sanos , Humanos , Dispositivos Laboratorio en un Chip , Proteómica/métodos , Análisis de Secuencia de ADN , Homología de Secuencia de Ácido Nucleico , Análisis de la Célula Individual/métodos , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/fisiología , Ursidae/microbiología
20.
Foodborne Pathog Dis ; 18(1): 8-15, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32865425

RESUMEN

This study was conducted to reveal the genotyping, antimicrobial susceptibility, and biofilm formation of Bacillus cereus isolated from powdered food products in China. Five hundred powdered food samples were collected from five provinces in China: 100 samples each of powdered infant formula (PIF), soy milk powder (SMP), lotus root powder (LRP), walnut powder (WP), and rice flour (RF). The genotyping of isolates was analyzed using multilocus sequence typing; meanwhile, antimicrobial susceptibility, and ability of biofilms formation on stainless steel tube of isolates were evaluated. Forty-two B. cereus strains were detected with an overall contamination rate of 8.4%, as well as, the highest B. cereus contamination rate was found in SMP (10%), followed by LRP (9%), WP (9%), RF (8%), and PIF (6%). These isolates were divided into 22 sequence types (STs); among them, ST32 (4/42, 9.5%) was the predominant ST. Phylogenetic relationships showed that the 42 strains of B. cereus were divided into three groups (group I, group II, and group III). Antimicrobial susceptibility testing indicated that all isolates were susceptible to tetracycline, gentamicin, erythromycin, and chloramphenicol, while resistant to ampicillin, cefepime, oxacillin, and rifampin. The analysis of ability of biofilm formation on stainless steel tube showed optical density (OD)595 value of 66.7% of B. cereus isolates was greater than 1. The OD595 level of isolates belonging to group III was higher compared with the other two groups, and OD595 values of B. cereus HB1 and HN5 were greater than 2. These findings improved the understanding of the characteristics of B. cereus isolated from powdered food products in China, and provided a theoretical basis for the prevention and control of B. cereus in food industry.


Asunto(s)
Bacillus cereus/aislamiento & purificación , Biopelículas/crecimiento & desarrollo , Farmacorresistencia Bacteriana/fisiología , Contaminación de Alimentos/análisis , Alimentos Especializados/microbiología , Bacillus cereus/genética , Bacillus cereus/fisiología , China , Microbiología de Alimentos , Genotipo , Humanos , Pruebas de Sensibilidad Microbiana , Filogenia , Polvos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA